跳至主要内容
临床试验/NCT03163680
NCT03163680已完成不适用

Efficacy of Low Dose of Proton Pumb Inhabitor in Treatment Upper Gastrointestinal Bleeding

Damascus Hospital1 个研究点 分布在 1 个国家目标入组 295 人开始时间: 2012年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
295
试验地点
1
主要终点
Morality

研究概览

简要总结

Determining the efficacy of low dose of PPI in management acute peptic ulcer bleeding

详细描述

Determining the efficacy of low dose meaning 40 mg of omeprazole twice in management acute peptic ulcer bleeding

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • High risk ulcers defined according to the Forrest classification With respect to high-risk stigmata, active bleeding was defined as a continuous blood spurting (Forrest IA) oozing (Forrest IB) from the ulcer base. A non-bleeding visible vessel at endoscopy was defined as a discrete protuberance at the ulcer base(Forrest IIA).
  • An adherent clot was one that was resistant to forceful irrigation or suction (Forrest IIB).

排除标准

  • ulcer was malignant non ulcerative bleeding such as angiodysplasia , a Mallory-Weiss tear

研究组 & 干预措施

Low Dose PPI

patients with upper upper gastrointestinal bleeding were treated in low dose of proton Bump inhibitor meaning 40 mg twice daily

干预措施: Omeprazole 40 MG (Drug)

结局指标

主要结局

Morality

时间窗: within 1 week

Determination of mortality rate from ulcer bleeding

次要结局

  • Rebleeding(within 1 week)
  • Length of hospital stay(within 1 month)
  • need for surgery(within 1 week)
  • Blood transfusions(within 1 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marouf Alhalabi

MD

Damascus Hospital

研究点 (1)

Loading locations...

相似试验